Twist Bioscience Corp — Director's Dealing 2018

Nov 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2018-11-02

Reporting Person: RAGUSA ROBERT P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-02	Common Stock	C	542203	—	Acquired	542203	Indirect
2018-11-02	Common Stock	C	329305	—	Acquired	871508	Indirect
2018-11-02	Common Stock	C	673378	—	Acquired	1544886	Indirect
2018-11-02	Common Stock	C	157215	—	Acquired	1702101	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-02	Series A Preferred Stock	$	C	542203	Disposed		Common Stock (542203)	Indirect
2018-11-02	Series B Preferred Stock	$	C	329305	Disposed		Common Stock (329305)	Indirect
2018-11-02	Series C Preferred Stock	$	C	673378	Disposed		Common Stock (673378)	Indirect
2018-11-02	Series D Preferred Stock	$	C	157215	Disposed		Common Stock (157215)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Footnotes

F1: The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock have no expiration date and converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.

F2: The Reporting Person is the Senior Vice President, Global Quality and Operations of Illumina, Inc. and has sole voting and dispositive power over the shares held of record by Illumina, Inc. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.